News
PPBT
1.590
+6.00%
0.090
Purple Biotech Unveils August 2026 Corporate Update on Tri-Specific Immuno-Oncology Platform
TipRanks · 20h ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 21h ago
Weekly Report: what happened at PPBT last week (0803-0807)?
Weekly Report · 1d ago
Purple Biotech Price Target Cut to $17.00/Share From $30.00 by HC Wainwright & Co.
Dow Jones · 4d ago
Purple Biotech Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 4d ago
HC Wainwright & Co. Maintains Buy on Purple Biotech, Lowers Price Target to $17
Benzinga · 4d ago
Purple Biotech price target lowered to $17 from $30 at H.C. Wainwright
TipRanks · 4d ago
Purple Biotech Posts Q2 2026 Results as IM1240 Preclinical Data Strengthen Immunotherapy Platform
TipRanks · 4d ago
Purple Biotech GAAP EPADS of -$0.41
Seeking Alpha · 4d ago
Purple Biotech Q2 EPS $(0.35) Beats $(0.98) Estimate
Benzinga · 4d ago
Purple Biotech Reports Second Quarter 2026 Financial Results
Barchart · 4d ago
Weekly Report: what happened at PPBT last week (0727-0731)?
Weekly Report · 08/03 09:44
Purple Biotech Sets September 8, 2026 AGM to Reshape Board Roles and Compensation Policy
TipRanks · 07/29 20:29
Weekly Report: what happened at PPBT last week (0720-0724)?
Weekly Report · 07/27 09:46
Weekly Report: what happened at PPBT last week (0713-0717)?
Weekly Report · 07/20 09:44
Weekly Report: what happened at PPBT last week (0706-0710)?
Weekly Report · 07/13 09:45
Weekly Report: what happened at PPBT last week (0629-0703)?
Weekly Report · 07/06 09:47
Weekly Report: what happened at PPBT last week (0622-0626)?
Weekly Report · 06/29 09:44
Purple Biotech Updates Investors on CAPTN-3 Platform and Pipeline as IM1240 Nears 2027 Clinic Entry
TipRanks · 06/23 14:49
Weekly Report: what happened at PPBT last week (0615-0619)?
Weekly Report · 06/22 09:49
More
Webull provides a variety of real-time PPBT stock news. You can receive the latest news about Purple Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.